Strategic Wealth Partners, Ltd. Gilead Sciences, Inc. Transaction History

Strategic Wealth Partners, Ltd.

$947 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$71.58 - $87.29 $569,061 - $693,955	-7,950 Closed	0 $0
Q4 2023 May 20, 2024	SELL	$73.27 - $83.09 $1.72 Million - $1.96 Million	-23,534 Reduced 74.75%	7,950 $644,000
Q3 2023 May 20, 2024	SELL	$73.94 - $80.67 $265,148 - $289,282	-3,586 Reduced 10.23%	31,484 $2.36 Million
Q2 2023 May 20, 2024	SELL	$76.01 - $86.7 $53,815 - $61,383	-708 Reduced 1.98%	35,070 $2.7 Million
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $79,938 - $91,074	-1,034 Reduced 2.81%	35,778 $2.97 Million
Q4 2022 Apr 24, 2023	SELL	$62.32 - $89.47 $2.03 Million - $2.91 Million	-32,495 Reduced 46.89%	36,812 $3.16 Million
Q3 2022 Apr 24, 2023	SELL	$59.54 - $68.01 $24,470 - $27,952	-411 Reduced 0.59%	69,307 $4.28 Million
Q2 2022 Aug 22, 2022	SELL	$57.72 - $65.01 $118,383 - $133,335	-2,051 Reduced 2.86%	69,718 $4.31 Million
Q1 2022 May 19, 2022	SELL	$57.92 - $72.58 $290,526 - $364,061	-5,016 Reduced 6.53%	71,769 $4.27 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $4.98 Million - $5.65 Million	76,785 New	76,785 $5.58 Million
Q4 2019 Jan 30, 2020	SELL	$61.62 - $67.78 $130,942 - $144,032	-2,125 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$62.51 - $69.0 $34,755 - $38,364	556 Added 35.44%	2,125 $46 Million
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $27,594 - $30,943	446 Added 39.72%	1,569 $105,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $8,441 - $9,456	135 Added 13.66%	1,123 $74,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $3,390 - $4,424	-56 Reduced 5.36%	988 $61,000
Q2 2018 Sep 04, 2018	SELL	$64.88 - $75.68 $35,619 - $41,548	-549 Reduced 34.46%	1,044 $74,000
Q1 2018 Jul 13, 2018	BUY	$72.84 - $88.8 $116,034 - $141,458	1,593 New	1,593 $120,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.

Account